572 related articles for article (PubMed ID: 28860764)
41. Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride-mediated oxidative hepatocellular damage in rat model.
Choudhury ST; Das N; Ghosh S; Ghosh D; Chakraborty S; Ali N
Int J Nanomedicine; 2016; 11():2179-93. PubMed ID: 27274242
[TBL] [Abstract][Full Text] [Related]
42. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
43. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
44. Properties, Extraction Methods, and Delivery Systems for Curcumin as a Natural Source of Beneficial Health Effects.
Zielińska A; Alves H; Marques V; Durazzo A; Lucarini M; Alves TF; Morsink M; Willemen N; Eder P; Chaud MV; Severino P; Santini A; Souto EB
Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32635279
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.
Farazuddin M; Dua B; Zia Q; Khan AA; Joshi B; Owais M
Int J Nanomedicine; 2014; 9():1139-52. PubMed ID: 24627632
[TBL] [Abstract][Full Text] [Related]
46. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models.
Lübtow MM; Nelke LC; Seifert J; Kühnemundt J; Sahay G; Dandekar G; Nietzer SL; Luxenhofer R
J Control Release; 2019 Jun; 303():162-180. PubMed ID: 30981815
[TBL] [Abstract][Full Text] [Related]
47. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
48. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
49. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.
Hou Y; Wang H; Zhang F; Sun F; Xin M; Li M; Li J; Wu X
Int J Nanomedicine; 2019; 14():557-571. PubMed ID: 30666114
[TBL] [Abstract][Full Text] [Related]
50. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry.
Padhye S; Chavan D; Pandey S; Deshpande J; Swamy KV; Sarkar FH
Mini Rev Med Chem; 2010 May; 10(5):372-87. PubMed ID: 20370702
[TBL] [Abstract][Full Text] [Related]
51. Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.
Harigae T; Nakagawa K; Miyazawa T; Inoue N; Kimura F; Ikeda I; Miyazawa T
Int J Nanomedicine; 2016; 11():3009-22. PubMed ID: 27418823
[TBL] [Abstract][Full Text] [Related]
52. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect.
Guo C; Hou X; Liu Y; Zhang Y; Xu H; Zhao F; Chen D
Phytomedicine; 2021 Jan; 80():153356. PubMed ID: 33039729
[TBL] [Abstract][Full Text] [Related]
53. Bioavailability of curcumin: problems and promises.
Anand P; Kunnumakkara AB; Newman RA; Aggarwal BB
Mol Pharm; 2007; 4(6):807-18. PubMed ID: 17999464
[TBL] [Abstract][Full Text] [Related]
54. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
[TBL] [Abstract][Full Text] [Related]
55. Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.
Pandelidou M; Dimas K; Georgopoulos A; Hatziantoniou S; Demetzos C
J Nanosci Nanotechnol; 2011 Feb; 11(2):1259-66. PubMed ID: 21456169
[TBL] [Abstract][Full Text] [Related]
56. Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis.
Jiang L; Wang J; Jiang J; Zhang C; Zhao M; Chen Z; Wang N; Hu D; Liu X; Peng H; Lian M
Eur J Pharm Biopharm; 2020 Jan; 146():101-110. PubMed ID: 31841689
[TBL] [Abstract][Full Text] [Related]
57. Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells.
Sheikhpour M; Sadeghizadeh M; Yazdian F; Mansoori A; Asadi H; Movafagh A; Shahraeini SS
Iran Biomed J; 2020 Jan; 24(1):24-9. PubMed ID: 31454860
[TBL] [Abstract][Full Text] [Related]
58. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
59. Critical parameters dictating efficiency of membrane-mediated drug transfer using nanoparticles.
Abbasi S; Kajimoto K; Harashima H
Int J Pharm; 2018 Dec; 553(1-2):398-407. PubMed ID: 30393168
[TBL] [Abstract][Full Text] [Related]
60. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
